Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $39

Benzinga · 2d ago
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $37 to $39.